Imperiale, F
Agosta, F
Canu, E
Markovic, V
Inuggi, A
Jecmenica-Lukic, M
Tomic, A
Copetti, M
Basaia, S
Kostic, V S
Filippi, M http://orcid.org/0000-0002-5485-0479
Article History
Received: 21 September 2016
Revised: 30 November 2016
Accepted: 9 January 2017
First Online: 7 March 2017
Competing interests
: FA is Section Editor ofNeuroImage: Clinicaland serves on the editorial board of theJournal of Neurology; has received speaker honoraria from EXCEMED—Excellence in Medical Education; and receives research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA) and the European Research Council. EC has received research support from the Italian Ministry of Health. VM has received research supports from the Ministry of Education and Science, Republic of Serbia. AI has received research supports from AriSLA—Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica. MC has received compensation for consulting and/or serving on advisory boards from Teva Pharmaceuticals and Biogen Idec. VSK serves on the editorial board of theJournal of Neurology; and has received research grants from Ministry of Education and Science, Republic of Serbia and the Serbian Academy of Science and Arts; he receives research supports from Valeant, Stada, Novartis and Boehriner Ingelheim, and speaker honoraria from Novartis and Boehringer Ingelheim. MF is Editor-in-Chief of theJournal of Neurology; serves on a scientific advisory board for Teva Pharmaceutical Industries; has received compensation for consulting services and/or speaking activities from Biogen Idec, ExceMED, Novartis and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Teva Pharmaceutical Industries, Novartis, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, Cure PSP, Alzheimer's Drug Discovery Foundation (ADDF), the Jacques and Gloria Gossweiler Foundation (Switzerland) and ARiSLA (Fondazione Italiana di Ricerca per la SLA). The remaining authors declare no conflict of interest.